Fostamatinib Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Fostamatinib is used to treat thrombocytopenia (less than normal number of platelets) in adults with chronic immune thrombocytopenia (ITP; an ongoing condition that may cause unusual bruising or bleeding due to an abnormally low number of platelets in the blood) who were not helped with another treatment.Fostamatinib Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Fostamatinib Nitroso Impurity 1 CAS NO:NA chemically represented as (6-((5-Fluoro-2-((3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)(nitroso)amino)-2,2-dimethyl-3-oxo-2,3-dihydro-4H-pyrido[3,2-b][1,4]oxazin-4-yl)methyl dihydrogen phosphate. Synchemia is the leading manufacturing and exporter of Fostamatinib Nitroso Impurity 1 . We supply Fostamatinib Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N014935 |
| CAS No | NA |
| Mol.F. | C16H22N4O3S |
| Mol.Wt. | 350.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014936 |
| CAS No | NA |
| Mol.F. | C30H40N6O3S |
| Mol.Wt. | 564.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014937 |
| CAS No | NA |
| Mol.F. | C30H40N6O3S |
| Mol.Wt. | 564.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014938 |
| CAS No | NA |
| Mol.F. | C30H39N7O4S |
| Mol.Wt. | 593.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014939 |
| CAS No | NA |
| Mol.F. | C19H28N4O3S |
| Mol.Wt. | 392.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014940 |
| CAS No | NA |
| Mol.F. | C17H24N4O4S |
| Mol.Wt. | 380.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014941 |
| CAS No | NA |
| Mol.F. | C11H16N4O3S |
| Mol.Wt. | 284.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014942 |
| CAS No | NA |
| Mol.F. | C17H24N4O3S |
| Mol.Wt. | 364.5 |
| INV STATUS | In Stock |
| CAT No | SRC-N014943 |
| CAS No | NA |
| Mol.F. | C16H21N5O4S |
| Mol.Wt. | 379.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014944 |
| CAS No | NA |
| Mol.F. | C17H24N4O4S |
| Mol.Wt. | 380.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014945 |
| CAS No | NA |
| Mol.F. | C17H24N4O4S |
| Mol.Wt. | 380.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014946 |
| CAS No | NA |
| Mol.F. | C45H40N6O3 |
| Mol.Wt. | 712.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014947 |
| CAS No | NA |
| Mol.F. | C39H36N6O3 |
| Mol.Wt. | 636.8 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014948 |
| CAS No | NA |
| Mol.F. | C20H21N3O3 |
| Mol.Wt. | 351.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014949 |
| CAS No | NA |
| Mol.F. | C24H28N6O4 |
| Mol.Wt. | 464.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014950 |
| CAS No | NA |
| Mol.F. | C24H28N6O4 |
| Mol.Wt. | 464.5 |
| INV STATUS | CUSTOM SYNTHESIS |